http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009111476-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8f4d0e74797969b473f7a8009a659b33 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1b2cd6bf9596eb0d60063ccec3c10475 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate | 2009-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ae248608fc1397aecffb4072780b49b |
| publicationDate | 2009-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2009111476-A2 |
| titleOfInvention | Assay for systematic lupus erthematosus |
| abstract | An assay for the presence of systemic lupus erythematosus (SLE) is disclosed. In one aspect, a specific a specific bacterial nucleic acid sequence of one or more of SEQ ID NOs: 1-9 is admixed with an analyte from the human to be diagnosed and the presence or absence of nucleic acid hybrid formation is determined. In another embodiment, antibodies from the human to be diagnosed are admixed with a promyelocyte Ehrlichiae Ep group antigen to form an antigen/antibody admixture that is maintained for a time period sufficient for immunoreaction and formation of an immunoreaction product, and the presence or absence of the immunoreaction product is determined. In each respective instance, nucleic acid hybrid formation or immunoreaction product formation indicates that the human has SLE. |
| priorityDate | 2008-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 130.